<?xml version="1.0" encoding="UTF-8"?>
<p id="p0140">Patients with cirrhosis or HCC had higher anti-HDV prevalence relative to comparator populations from the same geographic region, with pooled ORs of 6.7 and 4.8, respectively (
 <xref rid="fig5" ref-type="fig">Fig. 5</xref> and 
 <xref rid="appsec1" ref-type="sec">supplementary appendices 24 and 25</xref>). Among HBsAg-positive people with sequelae of infection, our PAF calculation suggested that HDV accounted for 18% of cirrhosis (95% CI 10–26) and 20% of HCC (95% CI 8–33) (
 <xref rid="appsec1" ref-type="sec">supplementary appendices 26</xref> and 
 <xref rid="appsec1" ref-type="sec">27</xref>).
</p>
